New Market Research Report: Analgesics in Israel
In 2012, the Israeli media focused on an incident caused by the popular analgesics brand, Optalgin. Five patients were said to have suffered damage to their bone marrow following the use of this popular analgesic. Optalgin, an analgesic which has dipyrone as its active ingredient, is known to cause agranulocitosys and is legal in Israel as an OTC drug although it is illegal in the US. At least two of the patients were relatively healthy people in their twenties. The...
View full press release